Cargando…

The prevalence of hyperuricemia in China: a meta-analysis

BACKGROUND: The prevalence of hyperuricemia varied in different populations and it appeared to be increasing in the past decades. Recent studies suggest that hyperuricemia is an independent risk factor for cardiovascular disease. However, there has not yet been a systematic analysis of the prevalenc...

Descripción completa

Detalles Bibliográficos
Autores principales: B, Liu, T, Wang, HN, Zhao, WW, Yue, HP, Yu, CX, Liu, J, Yin, RY, Jia, HW, Nie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3213156/
https://www.ncbi.nlm.nih.gov/pubmed/22032610
http://dx.doi.org/10.1186/1471-2458-11-832
_version_ 1782216091341160448
author B, Liu
T, Wang
HN, Zhao
WW, Yue
HP, Yu
CX, Liu
J, Yin
RY, Jia
HW, Nie
author_facet B, Liu
T, Wang
HN, Zhao
WW, Yue
HP, Yu
CX, Liu
J, Yin
RY, Jia
HW, Nie
author_sort B, Liu
collection PubMed
description BACKGROUND: The prevalence of hyperuricemia varied in different populations and it appeared to be increasing in the past decades. Recent studies suggest that hyperuricemia is an independent risk factor for cardiovascular disease. However, there has not yet been a systematic analysis of the prevalence of hyperuricemia in China. METHODS: Epidemiological investigations on hyperuricemia in China published in journals were identified manually and on-line by using CBMDISC, Chongqing VIP database and CNKI database. Those Reported in English journals were identified using MEDLINE database. Selected studies had to describe an original study defined by strict screening and diagnostic criteria. The fixed effects model or random effects model was employed according to statistical test for homogeneity. RESULTS: Fifty-nine studies were selected, the statistical information of which was collected for systematic analysis. The results showed that the pooled prevalence of hyperuricemia in male was 21.6% (95%CI: 18.9%-24.6%), but it was only 8.6% (95%CI: 8.2%-10.2%) in female. It was found that thirty years was the risk point age in male and it was fifty years in female. CONCLUSIONS: The prevalence of hyperuricemia is different as the period of age and it increases after 30 years in male and 50 in female. Interventions are necessary to change the risk factors before the key age which is 30 years in male and 50 in female.
format Online
Article
Text
id pubmed-3213156
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-32131562011-11-11 The prevalence of hyperuricemia in China: a meta-analysis B, Liu T, Wang HN, Zhao WW, Yue HP, Yu CX, Liu J, Yin RY, Jia HW, Nie BMC Public Health Research Article BACKGROUND: The prevalence of hyperuricemia varied in different populations and it appeared to be increasing in the past decades. Recent studies suggest that hyperuricemia is an independent risk factor for cardiovascular disease. However, there has not yet been a systematic analysis of the prevalence of hyperuricemia in China. METHODS: Epidemiological investigations on hyperuricemia in China published in journals were identified manually and on-line by using CBMDISC, Chongqing VIP database and CNKI database. Those Reported in English journals were identified using MEDLINE database. Selected studies had to describe an original study defined by strict screening and diagnostic criteria. The fixed effects model or random effects model was employed according to statistical test for homogeneity. RESULTS: Fifty-nine studies were selected, the statistical information of which was collected for systematic analysis. The results showed that the pooled prevalence of hyperuricemia in male was 21.6% (95%CI: 18.9%-24.6%), but it was only 8.6% (95%CI: 8.2%-10.2%) in female. It was found that thirty years was the risk point age in male and it was fifty years in female. CONCLUSIONS: The prevalence of hyperuricemia is different as the period of age and it increases after 30 years in male and 50 in female. Interventions are necessary to change the risk factors before the key age which is 30 years in male and 50 in female. BioMed Central 2011-10-27 /pmc/articles/PMC3213156/ /pubmed/22032610 http://dx.doi.org/10.1186/1471-2458-11-832 Text en Copyright ©2011 B et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
B, Liu
T, Wang
HN, Zhao
WW, Yue
HP, Yu
CX, Liu
J, Yin
RY, Jia
HW, Nie
The prevalence of hyperuricemia in China: a meta-analysis
title The prevalence of hyperuricemia in China: a meta-analysis
title_full The prevalence of hyperuricemia in China: a meta-analysis
title_fullStr The prevalence of hyperuricemia in China: a meta-analysis
title_full_unstemmed The prevalence of hyperuricemia in China: a meta-analysis
title_short The prevalence of hyperuricemia in China: a meta-analysis
title_sort prevalence of hyperuricemia in china: a meta-analysis
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3213156/
https://www.ncbi.nlm.nih.gov/pubmed/22032610
http://dx.doi.org/10.1186/1471-2458-11-832
work_keys_str_mv AT bliu theprevalenceofhyperuricemiainchinaametaanalysis
AT twang theprevalenceofhyperuricemiainchinaametaanalysis
AT hnzhao theprevalenceofhyperuricemiainchinaametaanalysis
AT wwyue theprevalenceofhyperuricemiainchinaametaanalysis
AT hpyu theprevalenceofhyperuricemiainchinaametaanalysis
AT cxliu theprevalenceofhyperuricemiainchinaametaanalysis
AT jyin theprevalenceofhyperuricemiainchinaametaanalysis
AT ryjia theprevalenceofhyperuricemiainchinaametaanalysis
AT hwnie theprevalenceofhyperuricemiainchinaametaanalysis
AT bliu prevalenceofhyperuricemiainchinaametaanalysis
AT twang prevalenceofhyperuricemiainchinaametaanalysis
AT hnzhao prevalenceofhyperuricemiainchinaametaanalysis
AT wwyue prevalenceofhyperuricemiainchinaametaanalysis
AT hpyu prevalenceofhyperuricemiainchinaametaanalysis
AT cxliu prevalenceofhyperuricemiainchinaametaanalysis
AT jyin prevalenceofhyperuricemiainchinaametaanalysis
AT ryjia prevalenceofhyperuricemiainchinaametaanalysis
AT hwnie prevalenceofhyperuricemiainchinaametaanalysis